FORM 4 ☒ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b...
UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549FORM 25 NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy Statement...
Filed by YishengBio Co., Ltd pursuant to Rule 425 under the Securities Act of 1933, as amended, and deemed filed pursuant to Rule...
0001839185 false 00000 0001839185 2023-02-21 2023-02-21 0001839185...
This regulatory filing was too large to post into our database. Please use the link below to view the original filing on the Securities and...
NASDAQ NASDAQ NASDAQ 00000 false 0001839185 0001839185 2023-02-03 2023-02-03 0001839185 us-gaap:CapitalUnitsMember 2023-02-03 2023-02-03...
UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549SCHEDULE 13GUnder the Securities Exchange Act of 1934(AMENDMENT NO...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G ...
NASDAQ NASDAQ NASDAQ 00000 false 0001839185 0001839185 2023-01-11 2023-01-11 0001839185 us-gaap:CapitalUnitsMember 2023-01-11 2023-01-11...
false0001839185Q3--12-310 0001839185 2022-09-30 0001839185 2021-12-31 0001839185 2022-01-01 2022-09-30 0001839185 2021-01-01 2021-09-30...
Filed by YishengBio Co., Ltd. Pursuant to Rule 425 under the Securities Act of 1933, as amended, and deemed filed pursuant to...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.